These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16324252)

  • 21. [A comparative study of E-cadherin mRNA expression in primary tumors and metastatic foci of gastric cancer].
    Yang J; Dai DQ
    Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):25-8. PubMed ID: 15771793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A decrease in the expression of CD63 tetraspanin protein elevates invasive potential of human melanoma cells.
    Jang HI; Lee H
    Exp Mol Med; 2003 Aug; 35(4):317-23. PubMed ID: 14508073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survivin expression in ovarian cancer.
    Liguang Z; Peishu L; Hongluan M; Hong J; Rong W; Wachtel MS; Frezza EE
    Exp Oncol; 2007 Jun; 29(2):121-5. PubMed ID: 17704744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ZEB2-Sp1 cooperation induces invasion by upregulating cadherin-11 and integrin α5 expression.
    Nam EH; Lee Y; Zhao XF; Park YK; Lee JW; Kim S
    Carcinogenesis; 2014 Feb; 35(2):302-14. PubMed ID: 24130169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study on the expression and mutation of cadherin 6 gene in human ovarian carcinoma].
    Li DR; Li L; Zhang W; Wang LM; Zhang JQ
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):616-9. PubMed ID: 15498191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
    Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calreticulin overexpression correlates with integrin-α5 and transforming growth factor-β1 expression in the atria of patients with rheumatic valvular disease and atrial fibrillation.
    Zhao F; Zhang S; Shao Y; Wu Y; Qin J; Chen Y; Chen L; Gu H; Wang X; Huang C; Zhang W
    Int J Cardiol; 2013 Oct; 168(3):2177-85. PubMed ID: 23465222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlation between integrin subunits alpha5 and beta1 expressions in prostate cancer and its clinical implication].
    Chen HJ; Wang H; Zhang L; Zhang YK; Wang GM
    Zhonghua Nan Ke Xue; 2006 Feb; 12(2):148-50. PubMed ID: 16519153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients.
    Rao ZY; Cai MY; Yang GF; He LR; Mai SJ; Hua WF; Liao YJ; Deng HX; Chen YC; Guan XY; Zeng YX; Kung HF; Xie D
    Carcinogenesis; 2010 Sep; 31(9):1576-83. PubMed ID: 20668008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of focal adhesion kinase and alpha5 and beta1 integrins in carcinomas and its clinical significance.
    Su JM; Gui L; Zhou YP; Zha XL
    World J Gastroenterol; 2002 Aug; 8(4):613-8. PubMed ID: 12174366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel orthotopic implantation model of human esophageal carcinoma in nude rats: CD44H mediates cancer cell invasion in vitro and in vivo.
    Hori T; Yamashita Y; Ohira M; Matsumura Y; Muguruma K; Hirakawa K
    Int J Cancer; 2001 May; 92(4):489-96. PubMed ID: 11304682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study on mRNA expression of the human novel gene NM23-H1B in ovarian tumor].
    Li W; Liu Y; Jin ZJ; Feng YJ; Huang LM; Chen J
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):48-51. PubMed ID: 16635329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of MTA2 gene in ovarian epithelial cancer and its clinical implication.
    Ji Y; Zhang P; Lu Y; Ma D
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(3):359-62. PubMed ID: 16961294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ZEB2 upregulates integrin α5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells.
    Nam EH; Lee Y; Park YK; Lee JW; Kim S
    Carcinogenesis; 2012 Mar; 33(3):563-71. PubMed ID: 22227038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD63/Pltgp40: a platelet activation antigen identical to the stage-specific, melanoma-associated antigen ME491.
    Azorsa DO; Hyman JA; Hildreth JE
    Blood; 1991 Jul; 78(2):280-4. PubMed ID: 2070066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression and significance of integrin alpha5, beta1 and E-CD in patients with non-small cell lung carcinoma].
    Guo QS; Jia H; Han MY; Yu JM; Zhong WX
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):746-9. PubMed ID: 17366785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expressions of Fas, CTLA-4 and RhoBTB2 genes in breast carcinoma and their relationship with clinicopathological factors].
    Bi Y; Wei L; Mao HT; Zhang L; Zuo WS
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):749-53. PubMed ID: 19173804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of human leukocyte antigen-G (HLA-G) expression and disease progression in epithelial ovarian cancer.
    Jung YW; Kim YT; Kim SW; Kim S; Kim JH; Cho NH; Kim JW
    Reprod Sci; 2009 Nov; 16(11):1103-11. PubMed ID: 19692629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
    Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J
    Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.